MOSCOW (Reuters) - Post-registration trials of Russia's second COVID-19 vaccine are expected to start on Sunday, Deputy Prime Minister Tatiana Golikova said, as authorities urged the population to cancel year-end holiday plans.
Russia in August became the first country to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing.
It has since developed a second inoculation and President Vladimir Putin said on Tuesday that it would soon register a third shot against the virus.
In comments published on Wednesday, Golikova said post-registration trials of Russia's second vaccine, developed by Siberia's Vector institute, were expected to begin on Sunday.
She added that Russia was planning to produce 500,000 doses of its main Sputnik V vaccine in November, lower than a previous forecast of 800,000 doses given by Trade and Industry Minister Denis Manturov.
The country's sovereign wealth fund said on Wednesday that interim trial results for the Sputnik V vaccine had shown it was 92% effective at protecting people from COVID-19.
Russia's results are only the second from a late-stage human trial, following on swiftly from data released on Monday by Pfizer Inc and BioNTech, which said their shot was also more than 90% effective.
While experts said the Russian data was encouraging, they warned that the results were only based on a small number of trial volunteers who had contracted COVID-19.
Despite Russia's efforts to develop vaccines, the country remains under strain from a recent surge in cases, reporting a record high of 432 deaths as well as 19,851 new infections on Wednesday.
Health Minister Mikhail Murashko called on the population to remain home with their families during New Year holidays, a period in early January when Russians often travel domestically and abroad, TASS news agency reported.
Bars, clubs and restaurants in Moscow, the sprawling capital of nearly 13 million people, will be closed overnight for a two-month period to contain the virus, the authorities said on Tuesday.
The city, which has recorded more than 485,000 cases since the start of the pandemic, will feel its economic effects until May 2021, Russian news agencies quoted Moscow Mayor Sergei Sobyanin as saying.
With 1,836,960 infections, Russia has the world's fourth largest number of cases behind the United States, India and Brazil.
(Reporting by Maria Kiselyova, Polina Ivanova, Gleb Stolyarov and Vladimir Soldatkin; Writing by Alexander Marrow and Gabrielle Tetrault-Farber; Editing by Nick Macfie)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU